AFib

The East trial was a game changer in terms of it confirmed what electrophysiologists have been thinking for years that rhythm control really is better but this study finally gave us the evidence we are hoping for. The other big new thing in AFib over the last I think really five maybe ten years is this whole issue of risk factor for modification and obesity. That data linking obesity and with AFib is so profound and the importance of weight loss as part of a treatment strategy is critical.